CTIS2024-510787-23-00招募中1 期
Maternal pertussis immunization in Finland, 4 years (MIFI-4Y) - MIFI-4Y
Varsinais-Suomen hyvinvointialue0 个研究点目标入组 138 人开始时间: 2024年1月11日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 138
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 0 至 64（—）
- 性别
- All
入选标准
- •Participation and completion of the 6-month timepoint in the original MIFI study will be the only inclusion criterion.
排除标准
- •The exclusion criteria include decline from or clinical conditions that disallow the study procedures.
研究者
相似试验
已完成
4 期
*Premature infants and maternal pertussis immunization. Is second trimester vaccination beneficial?*whooping coughpertussisNL-OMON49737RIVM6,750
进行中（未招募）
1 期
‘Premature infants and maternal pertussis immunization. Is second trimester vaccination beneficial?women in their first trimester of pregnancyEUCTR2018-002976-41-NLRIVM120
进行中（未招募）
1 期
TDaP (Tetanus, Diphtheria, acellular Pertussis) immunization during pregnancy results in an augmentation of maternal antibodies, which are in turn transferred from the mother to fetus and offer additional protection to the newborn infant during the first months of life. The role of these high maternal antibodies levels on the infant’s immune responses after vaccination will be assessed in term and preterm infants (the MAMA study).EUCTR2020-003466-39-BEniversity of Antwerp300
进行中（未招募）
1 期
Maternal pertussis Immunization in FInland Study - MIFI StudyPertussis InfectionMedDRA version: 20.0Level: PTClassification code 10034738Term: PertussisSystem Organ Class: 10021881 - Infections and infestationsEUCTR2019-001986-34-FITurku University Hospital160
进行中（未招募）
不适用
Maternal antibodies against pertussis in neonates .Pertussis disease is reported in very young children who have not yet been (fully) vaccinated and did not receive sufficient maternal antibodies. Augmenting maternal antibody titers by administering a prepregnancy booster in women is investigated as a way to protect young children.EUCTR2010-023976-16-BEniversity of Antwerp